Modifiers of Disease Severity in Cerebral Cavernous Malformations
Completed
Conditions studied: Cavernous Angioma, Familial, Cerebral Cavernous Malformations, Cerebral Cavernous Hemangioma
In brief
Cerebral cavernous malformations (CCMs) are clusters of abnormal blood vessels in the brain and spine. CCMs can bleed and cause strokes, seizures, and headaches. CCMs are often caused by an inherited gene mutation (alteration) in one of three CCM genes (CCM1, CCM2, or CCM3). There is a wide range of disease severity even among family members with this disease, though the natural history has not been clearly described for this particular population. This study will continue to enroll and follow participants with familial CCM to identify factors that influence CCM disease severity and progression, focusing on barriers to clinical trial preparedness. Our long-term goal is to identify measurable outcomes and robust biomarkers that will help select high-risk patients and help monitor drug response in future clinical trials. The specific goals of this study are to: * Identify factors that influence lesion progression to symptomatic hemorrhage and other outcomes, including quality of life; * Investigate the role of the gut microbiome and lesion burden in CCM disease, and * Identify blood biomarkers predictive of CCM disease severity and progression for clinical trials.
Key facts
- Study ID
- NCT01764529
- Run by
- University of California, San Francisco
- People needed
- 789
- Starts
- 2010-04-27
- Expected to finish
- 2025-06-30
- Last updated by the study team
- 2026-07-27
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Individual has a CCM mutation confirmed through DNA testing, or
- Individual meets 2 or more of the following clinical criteria:
- Clinical diagnosis of CCM
- Multi-focal CCMs on MRI
- Family history of CCM
You may not qualify if…
- Individuals who are incarcerated
- Individuals who are homeless
- Unable or unwilling to sign the informed consent
Where it is running
- Barrow Neurological Institute — Phoenix, Arizona, United States
- University of California, San Francisco — San Francisco, California, United States
- University of Chicago, Medicine and Biological Sciences — Chicago, Illinois, United States
- Boston Children's Hospital — Boston, Massachusetts, United States
- University of New Mexico Health Sciences Center — Albuquerque, New Mexico, United States
- Cincinnati Children's Hospital, Division of Pediatric Neurosurgery, Cerebrovascular Program — Cincinnati, Ohio, United States
- Alliance to Cure Cavernous Malformation — Charlottesville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.